Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary Radioactive Iodine Seed Localisation in the Axilla in Axillary Node Positive Breast Cancer Combined With Sentinel Node Procedure (RISAS) Following Neoadjuvant Chemotherapy

NCT02800317 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT02800317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02800317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary Radioactive Iodine Seed Localisation in the Axilla in Axillary Node Positive Breast Cancer Combined With Sentinel Node Procedure (RISAS) Following Neoadjuvant Chemotherapy
Lead sponsor
Erasmus Medical Center
Phase
Not applicable
Overall status
Completed
Start date
March 30, 2017
Completion date
December 3, 2021
Enrollment
248 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

axillary lymph nodes, breast neoplasm, neoadjuvant therapy, pathological complete response